Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Pain Practice : the Official Journal of World Institute of Pain
|
January 8, 2015
Findings of a Naloxone Database and its Utilization to Improve Safety and Education in a Tertiary Care Medical Center
David M Rosenfeld, Jeffrey A Betcher, Ruby A Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 14, 2013
Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch
James L Slack, Amylou C Dueck, Veena D Fauble, et al.
Leukemia & Lymphoma
|
January 11, 2019
Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter?
Tania Jain, Katie L Kunze, Banveet K Khetarpal, et al.
Leukemia & Lymphoma
|
July 7, 2018
Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation
Tania Jain, Heidi E Kosiorek, Thomas E Grys, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Pain Practice : the Official Journal of World Institute of Pain
|
January 8, 2015
Findings of a Naloxone Database and its Utilization to Improve Safety and Education in a Tertiary Care Medical Center
David M Rosenfeld, Jeffrey A Betcher, Ruby A Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 14, 2013
Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch
James L Slack, Amylou C Dueck, Veena D Fauble, et al.
Leukemia & Lymphoma
|
January 11, 2019
Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter?
Tania Jain, Katie L Kunze, Banveet K Khetarpal, et al.
Leukemia & Lymphoma
|
July 7, 2018
Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation
Tania Jain, Heidi E Kosiorek, Thomas E Grys, et al.
Page
of 2